Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

New treatment for adults with iron deficiency anaemia and inflammatory bowel disease launched

A new treatment for adults with iron deficiency anaemia and inflammatory bowel disease, who have previously failed on oral iron (ferrous) products, has been launched in the UK.

A new treatment for adults with iron deficiency anaemia (IDA) and inflammatory bowel disease (IBD), who have previously failed on oral iron (ferrous) products, has been launched in the UK. Ferric maltol (Feraccru), by Shield Therapeutics PLC, is a novel and effective oral ferric treatment for IDA and provides a new oral ferric alternative for adult IBD patients with IDA who have failed oral ferrous products and is a well-tolerated oral alternative to intravenous (IV) iron in mild-moderate IBD patients. The symptoms of IDA in IBD (e.g. fatigue) can have a significant impact on patients’ activities of daily living, including

---------------------------

This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.

Existing Users Log In
   
New User Registration
captcha
*Required field

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy